European association of nuclear medicine procedure guidelines for brain neurotransmission SPET using123I-labelled dopamine transporter ligands

European Journal of Nuclear Medicine

Volumn 29, Issue 10, 2002, Pages

  Tatsch, K ^a   Asenbaum, S ^a   Bartenstein, P ^a   Catafau, A ^a   Halldin, C ^a   Pilowsky, L S ^a   Pupi, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER I 123; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; IODINE 123; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA(4 IODOPHENYL)NORTROPANE; RADIOLIGAND; UNCLASSIFIED DRUG; COCAINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RACLOPRIDE; TECHNETIUM 99M; CARRIER PROTEIN; DIAGNOSTIC AGENT; LIGAND; MEMBRANE PROTEIN; NERVE PROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ANAMNESIS; BINDING AFFINITY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOSIMETRY; EARLY DIAGNOSIS; ERROR; EUROPE; FILTRATION; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; INJECTION; LIGAND BINDING; MEDICAL ASSESSMENT; MEDICAL SOCIETY; NEUROTRANSMISSION; NUCLEAR MEDICINE; PARKINSON DISEASE; PARKINSONISM; PATIENT INFORMATION; PRACTICE GUIDELINE; PREGNANCY; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; IN VIVO STUDY; MEDICAL PRACTICE; PHYSICIAN; ARTICLE; BRAIN MAPPING; INTERNATIONAL COOPERATION; METABOLISM; METHODOLOGY; PHYSIOLOGY; SCINTISCANNING; STANDARD; SYNAPTIC TRANSMISSION;

BRAIN; BRAIN MAPPING; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EUROPE; HUMANS; INTERNATIONAL COOPERATION; IODINE RADIOISOTOPES; LIGANDS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR MEDICINE; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; SOCIETIES, MEDICAL; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036384883     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Bartenstein P, Grünwald F, Kuwert T, Tatsch K, Sabri O, Benkert O, Fahlbusch R, Gründer G, Herholz K, Weiller C. Clinical applications of single photon emission tomography in neuromedicine. 1. Neurooncology, epilepsy, movement disorders, cerebrovascular disease. Nuklearmedizin 2000; 39:180-195.
2. Juni JE, Waxman AD, Devous MD, et al. Procedure guideline for brain perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals. J Nucl Med 1998; 39:923-926.
3. Society of Nuclear Medicine Brain Imaging Council. Ethical clinical practice of functional brain imaging. J Nucl Med 1996; 37:1256-1259.
4. Verhoeff NPLG. Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders. Psychopharmacology 1999; 147:217-249.
5. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 1999; 26:171-182.
6. Tatsch K. Imaging of the dopaminergic system in parkinsonism with SPET. Nucl Med Commun 2001; 22:819-827.
7. Halldin C, Gulyas B, Langer O, Farde L. Brain radioligands - state of the art and new trends. Q J Nucl Med 2001; 45:139-152.
8. 123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998; 105:12131228.
9. 123I]-FP-CIT study group. Mov Disord 2000; 15:503-510.
10. 123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998; 43:792-800.
11. 123I]-FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 2001; 28:266-272.
12. 123I]β-CIT SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 1996; 46:231-237.
13. Booij J, Tissingh G, Boer GJ, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62:133-140.
14. 123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995; 38:589-598.
15. Rinne JO, Kuikka JT, Bergström KA, et al. Striatal dopamine transporter in different disability stages of Parkinson's disease. Parkinsonism Related Disorders 1995; 1:47-51
16. 123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 1997; 50:9-24.
17. Asenbaum S, Brücke T, Pirker W, et al. Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease. J Nucl Med 1997; 38:1-6.
18. 123I]β-CIT SPECT. J Neural Transm 2000; 107:543-552.
19. Chouker M, Tatsch K, Linke R, Pogarell O, Hahn K, Schwarz J. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years. Nucl Med Commun 2001; 22:721-725.
20. 123I]β-CIT. Mov Disord 1999; 14:436-442.
21. Ahlskog JE, Uitti RJ, O'Connor MK, et al. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord 1999; 14:940-946.
22. Seibyl JP, Wallace E, Smith EO, et al. Whole body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects. J Nucl Med 1994; 35:764-770
23. Kuikka JT, Bergstrom KA, Ahonen A, Lansimies E. The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane. Eur J Nucl Med 1994; 21:53-56.
24. 123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med 1998; 25:24-30.
25. Habraken JB, Booij J, Slomka P, Sokole EB, van Royen EA. Quantification and visualisation of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med 1999; 40:1091-1097.